Catholic Medical Mission Board, Inc.

Audits
4
Findings
20
Total Expended
$56.35M
Latest Accepted
2026-05-13
Location: New York, NY
UEI: LJ4BYCD34UJ9 EIN: 135602319

SAM.gov Exclusion Status:

Checking exclusion status...

Audits by Year

  • 2022 1
  • 2023 1
  • 2024 1
  • 2025 1
Loading recommendations...

Contacts

Name Title Type
Carmen Korf Chief Financial Officer (Interim) Auditee
David Damond Chief Financial Officer Auditee
Sibi Thomas Shareholder Auditee
Edward Miller Partner Auditee
No contacts on file

Recent Audits

ID Year Date Accepted Auditor Spend
401280 2025 2026-05-13 GRANT THORNTON LLP $16.15M
360404 2024 2025-06-27 Grant Thornton LLP $16.39M
302514 2023 2024-04-03 Mayer Hoffman McCann CPAS $9.96M
73576 2022 2023-03-16 Mayer Hoffman McCann CPAS $13.85M

Audit Findings

Audit Year Accepted Finding Ref Severity Repeat Requirement
401280 2025 2026-05-13 1214609 2025-001 Material Weakness Yes L
401280 2025 2026-05-13 1214608 2025-001 Material Weakness Yes L
401280 2025 2026-05-13 1214607 2025-001 Material Weakness Yes L
401280 2025 2026-05-13 1214606 2025-001 Material Weakness Yes L
360404 2024 2025-06-27 1144477 2024-005 Material Weakness - L
360404 2024 2025-06-27 1144476 2024-005 Material Weakness - L
360404 2024 2025-06-27 1144475 2024-005 Material Weakness - L
360404 2024 2025-06-27 1144474 2024-005 Material Weakness - L
360404 2024 2025-06-27 1144473 2024-004 Significant Deficiency - B
360404 2024 2025-06-27 1144472 2024-004 Significant Deficiency - B
360404 2024 2025-06-27 1144471 2024-004 Significant Deficiency - B
360404 2024 2025-06-27 1144470 2024-004 Significant Deficiency - B
360404 2024 2025-06-27 568035 2024-005 Material Weakness - L
360404 2024 2025-06-27 568034 2024-005 Material Weakness - L
360404 2024 2025-06-27 568033 2024-005 Material Weakness - L
360404 2024 2025-06-27 568032 2024-005 Material Weakness - L
360404 2024 2025-06-27 568031 2024-004 Significant Deficiency - B
360404 2024 2025-06-27 568030 2024-004 Significant Deficiency - B
360404 2024 2025-06-27 568029 2024-004 Significant Deficiency - B
360404 2024 2025-06-27 568028 2024-004 Significant Deficiency - B